Kinnate Biopharma Shares Halted, News Pending
Portfolio Pulse from Benzinga Newsdesk
Shares of Kinnate Biopharma have been halted due to pending news. Further details are yet to be released.

September 18, 2023 | 8:05 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Kinnate Biopharma's shares have been halted due to pending news. The nature of the news could significantly impact the stock's performance.
The halt in trading of Kinnate Biopharma's shares indicates that there is significant news pending. Depending on the nature of this news, it could have a substantial impact on the company's stock performance. However, without further details, it's difficult to predict the direction of the impact.
CONFIDENCE 80
IMPORTANCE 100
RELEVANCE 100